Natural language processing diagnosed behavioral disturbance vs confusion assessment method for the intensive care unit: prevalence, patient characteristics, overlap, and association with treatment and outcome
Purpose To compare the prevalence, characteristics, drug treatment for delirium, and outcomes of patients with Natural Language Processing (NLP) diagnosed behavioral disturbance (NLP-Dx-BD) vs Confusion Assessment Method for intensive care unit (CAM-ICU) positivity. Methods In three combined medical...
Gespeichert in:
Veröffentlicht in: | Intensive care medicine 2022-05, Vol.48 (5), p.559-569 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Purpose
To compare the prevalence, characteristics, drug treatment for delirium, and outcomes of patients with Natural Language Processing (NLP) diagnosed behavioral disturbance (NLP-Dx-BD) vs Confusion Assessment Method for intensive care unit (CAM-ICU) positivity.
Methods
In three combined medical-surgical ICUs, we obtained data on demographics, treatment with antipsychotic medications, and outcomes. We applied NLP to caregiver progress notes to diagnose behavioral disturbance and analyzed simultaneous CAM-ICU.
Results
We assessed 2313 patients with a median lowest Richmond Agitation-Sedation Scale (RASS) score of − 2 (− 4.0 to − 1.0) and median highest RASS score of 1 (0 to 1). Overall, 1246 (53.9%) patients were NLP-Dx-BD positive (NLP-Dx-BD
pos
) and 578 (25%) were CAM-ICU positive (CAM-ICU
pos
). Among NLP-Dx-BD
pos
patients, 539 (43.3%) were also CAM-ICU
pos
. In contrast, among CAM-ICU
pos
patients, 539 (93.3%) were also NLP-Dx-BD
pos
. The use of antipsychotic medications was highest in patients in the CAM-ICU
pos
and NLP-Dx-BD
pos
group (24.3%) followed by the CAM-ICU
neg
and NLP-Dx-BD
pos
group (10.5%). In NLP-Dx-BD
neg
patients, antipsychotic medication use was lower at 5.1% for CAM-ICU
pos
and NLP-Dx-BD
neg
patients and 2.3% for CAM-ICU
neg
and NLP-Dx-BD
neg
patients (overall
P
|
---|---|
ISSN: | 0342-4642 1432-1238 1432-1238 |
DOI: | 10.1007/s00134-022-06650-z |